AR050931A1 - Un procedimiento para fabricar compuestos enantiomericos del imidazol que comprenden el r- sertaconazol y compuesto obtenido - Google Patents

Un procedimiento para fabricar compuestos enantiomericos del imidazol que comprenden el r- sertaconazol y compuesto obtenido

Info

Publication number
AR050931A1
AR050931A1 ARP050103794A ARP050103794A AR050931A1 AR 050931 A1 AR050931 A1 AR 050931A1 AR P050103794 A ARP050103794 A AR P050103794A AR P050103794 A ARP050103794 A AR P050103794A AR 050931 A1 AR050931 A1 AR 050931A1
Authority
AR
Argentina
Prior art keywords
imidazol
sertaconazol
understand
procedure
manufacturing
Prior art date
Application number
ARP050103794A
Other languages
English (en)
Spanish (es)
Inventor
Ines Petschen
Xavier Camps
Juan Sallares
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35614444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR050931(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of AR050931A1 publication Critical patent/AR050931A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP050103794A 2004-09-13 2005-09-12 Un procedimiento para fabricar compuestos enantiomericos del imidazol que comprenden el r- sertaconazol y compuesto obtenido AR050931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200402184A ES2249992B1 (es) 2004-09-13 2004-09-13 Un procedimiento para fabricar compuestos enantiomericos del imidazol.

Publications (1)

Publication Number Publication Date
AR050931A1 true AR050931A1 (es) 2006-12-06

Family

ID=35614444

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103794A AR050931A1 (es) 2004-09-13 2005-09-12 Un procedimiento para fabricar compuestos enantiomericos del imidazol que comprenden el r- sertaconazol y compuesto obtenido

Country Status (23)

Country Link
US (1) US7626038B2 (cg-RX-API-DMAC7.html)
EP (1) EP1794152B1 (cg-RX-API-DMAC7.html)
JP (1) JP5048500B2 (cg-RX-API-DMAC7.html)
KR (1) KR100903922B1 (cg-RX-API-DMAC7.html)
CN (1) CN101023077B (cg-RX-API-DMAC7.html)
AR (1) AR050931A1 (cg-RX-API-DMAC7.html)
AT (1) ATE402171T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005284330B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515259A (cg-RX-API-DMAC7.html)
CA (1) CA2577247C (cg-RX-API-DMAC7.html)
DE (1) DE602005008454D1 (cg-RX-API-DMAC7.html)
DK (1) DK1794152T3 (cg-RX-API-DMAC7.html)
ES (1) ES2249992B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007002939A (cg-RX-API-DMAC7.html)
NO (1) NO20071817L (cg-RX-API-DMAC7.html)
PA (1) PA8645501A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060720A1 (cg-RX-API-DMAC7.html)
PL (1) PL1794152T3 (cg-RX-API-DMAC7.html)
PT (1) PT1794152E (cg-RX-API-DMAC7.html)
RU (1) RU2413728C2 (cg-RX-API-DMAC7.html)
TW (1) TWI405760B (cg-RX-API-DMAC7.html)
UY (1) UY29115A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006029811A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8635593B2 (en) * 2008-05-13 2014-01-21 Hewlett-Packard Development Company, L.P. Dynamic autocompletion tool
CN112595803A (zh) * 2020-12-31 2021-04-02 海南海神同洲制药有限公司 一种硝酸舍他康唑乳膏的鉴别方法
CN113501814A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑的纯化方法
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113501815A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑晶型的制备方法
CN113816947A (zh) * 2021-08-25 2021-12-21 海南海神同洲制药有限公司 一种硝酸舍他康唑的重结晶方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1096361B (it) 1978-05-18 1985-08-26 Recordati Chem Pharm Dibenzileteri sostituiti terapeuticamente attivi
JPS57169466A (en) 1981-04-14 1982-10-19 Ota Seiyaku Kk Preparation of imidazole derivative
ES8504779A1 (es) * 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
CA1250586A (en) 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
JP3250809B2 (ja) * 1995-01-04 2002-01-28 フエルレル インターナショナル,ソシエダッド アノニマ 1−[2,4−ジクロロ−β−[(7−クロロベンゾ[b]チエニ−3−イル)メトキシ]フェネチル]イミダゾール・1硝酸塩の同質異像B及びC
CZ20012338A3 (cs) * 1998-12-24 2001-12-12 Fujisawa Pharmaceutical Co., Ltd. Imidazolové sloučeniny
CN1191250C (zh) * 2001-09-26 2005-03-02 河北省药物研究所 一种硝酸舍他康唑的合成方法
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.

Also Published As

Publication number Publication date
TW200621756A (en) 2006-07-01
PL1794152T3 (pl) 2008-12-31
US20080108682A1 (en) 2008-05-08
KR20070042206A (ko) 2007-04-20
RU2007113921A (ru) 2008-10-20
UY29115A1 (es) 2005-11-30
JP5048500B2 (ja) 2012-10-17
TWI405760B (zh) 2013-08-21
KR100903922B1 (ko) 2009-06-19
PT1794152E (pt) 2008-10-24
ATE402171T1 (de) 2008-08-15
ES2249992B1 (es) 2007-03-01
US7626038B2 (en) 2009-12-01
WO2006029811A1 (en) 2006-03-23
DK1794152T3 (da) 2008-11-17
RU2413728C2 (ru) 2011-03-10
EP1794152A1 (en) 2007-06-13
MX2007002939A (es) 2007-04-27
CA2577247A1 (en) 2006-03-23
NO20071817L (no) 2007-05-16
EP1794152B1 (en) 2008-07-23
PA8645501A1 (es) 2006-05-16
BRPI0515259A (pt) 2008-07-15
HK1105416A1 (en) 2008-02-15
JP2008512421A (ja) 2008-04-24
CA2577247C (en) 2011-07-05
DE602005008454D1 (de) 2008-09-04
CN101023077A (zh) 2007-08-22
PE20060720A1 (es) 2006-07-11
AU2005284330A1 (en) 2006-03-23
CN101023077B (zh) 2012-05-23
AU2005284330B2 (en) 2011-01-06
ES2249992A1 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
EP2123636A4 (en) PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE
NZ599684A (en) Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
PE20091582A1 (es) Procedimiento para la preparacion de dihidropteridinonas
ATE353081T1 (de) Verfahren zur herstellung von duloxetin und deren verwendeten zwischenprodukten
PE44599A1 (es) Inhibidores de la enzima acido nitrico sintasa
CO5630034A1 (es) Metodo para producir esteres de alquilo
AR007695A1 (es) Procedimiento para preparar fenilheterociclos utiles como inhibidores de cox-2
IS2060B (is) Aðferð til framleiðslu á hreinu sítalóprami
ES2189251T3 (es) Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2'.
AR055993A1 (es) Proceso para producir 3-oxo-pregnano-21,17-carbolactonas, asi como 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion del correspondiente 17-(3-hidroxipropil)-3,17-dihidroxiandrostano
Alinezhad et al. Protic pyridinium ionic liquid: As an efficient, green and environmentally friendly catalyst for the one-pot synthesis of amidoalkyl naphthol derivatives
BR0213814A (pt) Processos para a fabricação de 3-hidroxi-n, 1,6-trialquil-4-oxo-1, 4-diidro piridino-2-carboxamida
JP2010510253A5 (cg-RX-API-DMAC7.html)
CN105801459B (zh) 一锅法制备芳基磺酸三氟甲硫酯系列化合物的方法
EP1787991A4 (en) PYRROLO [2,3-c] PYRIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF
EP1894973A4 (en) METHOD FOR PRODUCING A PVP-FULLER COMPLEX AND AQUEOUS SOLUTION THEREOF
ECSP066271A (es) Un método para la preparación de mirtazapina enantioméricamente pura
PE20060720A1 (es) Procedimiento para fabricar r-(-)-sertaconazol mononitrato
BR0300726A (pt) Método e aparelho para a produção de ácido poliacrìlico
EP1911775A4 (en) METHOD FOR PRODUCING NETWORKED POLY (METH) ACRYLIC NITROXIDE COMPOUNDS
AR047740A1 (es) Un procedimiento para la sintesis de (7-metoxi-1-naftilo)acetonitrilo y su aplicacion en la sintesis de agomelatina
RU2006115883A (ru) Комплексное соединение 1,3-бис(2-гидроксиэтил)-5-гидрокси-6-метилурацила с фумаровой кислотой, проявляющее антигипоксическую активность и способ его получения
JP2011503175A5 (cg-RX-API-DMAC7.html)
AR074151A1 (es) Un derivado de benzoilbencenoacetamida, proceso de preparacion del mismo, forma polimorfica b de dicho compuesto, proceso de obtencion de dicha forma polimorfica b y su uso
ATE425959T1 (de) Verfahren zur herstellung von amino- oder hydroxybenzonitrilen

Legal Events

Date Code Title Description
FC Refusal